https://www.casselsalpeter.com/wp-content/uploads/2019/11/SCI_logo.jpg 250 250 roaradmin http://www.casselsalpeter.com/wp-content/uploads/2020/04/cs_logo-color-REPLACE.png roaradmin2018-08-02 17:28:312020-07-01 15:00:43Sancilio sold certain assets to K.D. Pharma Bexbach
- Background: Sancilio Pharmaceuticals Company, Inc. (“Sancilio”), based in Riviera Beach, FL, is an integrated specialty pharmaceutical company that develops, manufactures, and commercializes pharmaceutical products, over-the-counter and behind-the-counter products, and dietary supplements in the dental and women’s health markets.
- Cassel Salpeter:
- Served as financial advisor to the Company
- Ran a competitive sales process, identifying and contacting over 300 strategic and financial parties
- Provided assistance throughout all phases of the Chapter 11 Section 363 sales process, due diligence, and auction
- Expedited sales timeline with less than six weeks to identify and solicit interest from potential bidders
- Simultaneous, multiple sales processes for different divisions of the Company
- Outcome: On August 1, 2018, the Ocean Blue division of Sancilio Pharmaceuticals Company, Inc. was purchased by K.D. Pharma Bexbach GmbH, headquartered in Bexbach, Germany.